Merck (NYSE: MRK) spinoff Organon (NYSE:OGN) today announced the completion of its acquisition of Alydia Health for up to $240 million. Alydia Health develops treatments centered around preventing maternal morbidity and mortality caused by postpartum hemorrhage (PPH) or abnormal postpartum uterine bleeding. The company designed its Jada system to control and treat abnormal postpartum uterine […]
alydiahealth
Alydia Health appoints VP of sales
Alydia Health this week said it has appointed Paul Praino as its VP of sales. Praino will be responsible for expanding the company’s sales efforts for the Jada System, Alydia Health’s device that is designed to encourage normal contraction of the uterus to rapidly stop excessive bleeding after childbirth. “Paul is an experienced commercial sales […]
Merck spinoff Organon to acquire Alydia Health for up to $240M
Merck (NYSE: MRK) announced today that it entered into an agreement for its spinoff Organon to acquire Alydia Health for up to $240 million. Alydia Health develops treatments focusing on preventing maternal morbidity and mortality caused by postpartum hemorrhage (PPH) or abnormal postpartum uterine bleeding, according to a news release. The company develops the Jada […]
Alydia Health raises $10m in Series B
Alydia Health, formerly known as InPress Technologies, said today it closed a $10 million Series B financing round to help support its technology platform designed to prevent maternal morbidity and mortality caused by postpartum hemorrhage. The round was led by the Global Health Investment Fund and joined by Astia Angles and other existing investors. As […]